Patents by Inventor Burkhart Shraven

Burkhart Shraven has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Bispecific molecules recognizing lymphocyte antigen CD2 and tumor antigens
    Patent number: 5798229
    Abstract: The present invention relates to novel and highly effective bispecific antibody fragments which recognize lymphocyte CD2 antigen and any variable tumor antigen. Moreover, the invention relates to two new monoclonal antibodies terms AICD2.M1 and AICD2.M2. A combination of these antibodies, whereby at least one of them is a bispecific antibody fragment, can be used successfully in tumor therapy and diagnostics.
    Type: Grant
    Filed: August 2, 1994
    Date of Patent: August 25, 1998
    Assignee: Merck Patent Gesellschaft mit beschrankter Haftung
    Inventors: Wolfgang Strittmatter, Carlota-Silvia Jaggle, Stefan Meuer, Burkhart Shraven, Martin Wild